Source: Annual Congress 2010 - Staging of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Dushianthan, A. Bhatta, J. A. Benjamin (Llantrisant, United Kingdom). Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients. Eur Respir J 2010; 36: Suppl. 54, 5445

Member's Comments

No comment yet.

Related content which might interest you: A lung cancer patient with multiple lesions on PET scan Source: Annual Congress 2006 - Clinical Grand Round: an interactive session Year: 2006 PET/CT of lung cancer Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018 Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 The role of PET/CT in lung cancer staging Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 PET scan in stage IA lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 436s Year: 2007 Mediastinoscopy versus CT and PET in preoperative N-staging of lung cancer Source: Annual Congress 2009 - Current challenges in thoracic surgery Year: 2009 Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004 Computed tomography in staging for lung cancer Source: Eur Respir J 2002; 19: 40S-48S Year: 2002 The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008 Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005 Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Utility of PET/CT in staging of lung cancer: Results from 245 patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Pulmonary metastases in patients with breast cancer: thin-section CT findings in 29 patients Source: Eur Respir J 2006; 28: Suppl. 50, 776s Year: 2006